The neuroprotection market in North America is experiencing significant growth due to several key drivers such as the increasing prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis in the region. As the aging population continues to rise, the demand for effective neuroprotective therapies and interventions is...